EchoStar Shares Rally as Earnings Beat Clashes With Valuation Warnings
EchoStar Corporation shares surged after posting better-than-expected quarterly earnings, though valuation metrics and heavy insider selling have prompted warnings about the stock's current price.
EchoStar Corporation shares rose 6.9% to reach $101.19 on November 09, 2026, extending a strong run that has lifted the equity 37.7% over the past year. The communication and connectivity company has traded within a 52-week range of $65.76 to $147.25, demonstrating sharp volatility throughout recent market sessions.
Despite the advance, valuation models from GuruFocus indicate that the stock may be stretched. GuruFocus calculated a proprietary intrinsic value of $17.88, concluding that EchoStar is 465.9% overvalued. Although the stock earned an above-average overall score of 67 out of 100 alongside a top momentum mark of 10 out of 10, its valuation rank stood at 1 out of 10. Financial data shows EchoStar with a price-to-earnings ratio of 3.7x, below its five-year median of 16.1x.
The recent price surge follows strong quarterly earnings released on Tuesday, November 3rd. EchoStar delivered earnings per share of $7.97, surpassing consensus projections of $3.07 by $4.90. The company generated $1.13 billion in revenue for the quarter, compared with consensus estimates of $3.00 million, while producing a net margin of 81.29% and a return on equity of 22.85%.
Wall Street brokerages have maintained an optimistic stance following the results. Consensus data compiled by MarketBeat shows an overall "Buy" rating with an average target price of $139.44. Recent individual updates include Morgan Stanley lowering its price target from $134.00 to $132.00 with an "overweight" rating, while UBS Group lifted its target from $150.00 to $160.00. Across tracked analyst ratings, seven recommend buying the shares, two rate it a "Strong Buy," and one recommends selling.
Institutional and insider actions present a more cautious picture. GuruFocus reported that corporate insiders sold a net $57.3 million in company stock over the past 12 months, compared to just $0.1 million in purchases. In the third quarter, institutional funds also trimmed holdings, with Oppenheimer & Co. Inc. cutting its stake by 90.0% through the sale of 23,715 shares, and Sumitomo Mitsui Trust Group Inc. lowering its position by 21.2% by selling 69,447 shares.